Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2019 Results Earnings Conference Call February 5, 2019 4:30 PM ET Company Participants Scott Gleason - VP of IR Mark Capone - CEO, President Bryan Riggsbee - Executive VP, CFO & Treasurer Conference Call Participants Steve Beuchaw - Morgan Stanley Doug Schenkel - Cowen & Company Patrick Donnelly - Goldman Sachs Puneet Souda - SVB Leerink Partners Bill Quirk - Piper Jaffray Tycho Peterson - JPMorgan Jack Meehan - Barclays Derik De Bruin - Bank of America Merrill Lynch D ...